当前位置: X-MOL 学术Neuroradiology › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Impact of brain tumors and radiotherapy on the presence of gadolinium in the brain after repeated administration of gadolinium-based contrast agents: an experimental study in rats.
Neuroradiology ( IF 2.4 ) Pub Date : 2019-07-11 , DOI: 10.1007/s00234-019-02256-3
Gregor Jost 1 , Thomas Frenzel 1 , Janina Boyken 1 , Hubertus Pietsch 1
Affiliation  

PURPOSE To investigate the impact of blood-brain barrier (BBB) alterations induced by an experimental tumor and radiotherapy on MRI signal intensity (SI) in deep cerebellar nuclei (DCN) and the presence of gadolinium after repeated administration of a linear gadolinium-based contrast agent in rats. METHODS Eighteen Fischer rats were divided into a tumor (gliosarcoma, GS9L model), a radiotherapy, and a control group. All animals received 5 daily injections (1.8 mmol/kg) of gadopentetate dimeglumine. For tumor-bearing animals, the BBB disruption was confirmed by contrast-enhanced MRI. Animals from the tumor and radiation group underwent radiotherapy in 6 fractions of 5 Gray. The SI ratio between DCN and brain stem was evaluated on T1-weigthed MRI at baseline and 1 week after the last administration. Subsequently, the brain was dissected for gadolinium quantification by inductively coupled plasma-mass spectrometry. Statistical analysis was done with the Kruskal-Wallis test. RESULTS An increased but similar DCN/brain stem SI ratio was found for all three groups (p = 0.14). The gadolinium tissue concentrations (median, nmol/g) were 6.7 (tumor), 6.3 (radiotherapy), and 6.8 (control) in the cerebellum (p = 0.64) and 17.8/14.6 (tumor), 20.0/18.9 (radiotherapy), and 17.8/15.9 (control) for the primary tumor (p = 0.98) and the contralateral hemisphere (p = 0.41) of the cerebrum, respectively. CONCLUSION An experimental brain tumor treated by radiotherapy or radiotherapy alone did not alter DCN signal hyperintensity and gadolinium concentration in the rat brain 1 week after repeated administration of gadopentetate. This suggests that a local BBB disruption does not affect the amount of retained gadolinium in the brain.

中文翻译:

重复施用钆造影剂后脑肿瘤和放射治疗对大脑中钆存在的影响:一项在大鼠中进行的实验研究。

目的 研究实验性肿瘤和放疗引起的血脑屏障 (BBB) 改变对小脑深部核团 (DCN) MRI 信号强度 (SI) 的影响以及重复施用线性钆对比剂后钆存在的影响大鼠体内的代理。方法18只Fischer大鼠分为肿瘤组(胶质肉瘤,GS9L模型)、放疗组和对照组。所有动物每天接受 5 次钆喷酸二葡胺注射(1.8 mmol/kg)。对于荷瘤动物,BBB 破坏通过对比增强 MRI 得到证实。肿瘤组和放射组的动物以 5 格雷为 6 次进行放射治疗。在基线时和最后一次给药后 1 周,通过 T1 加权 MRI 评估 DCN 和脑干之间的 SI 比率。随后,解剖大脑,通过电感耦合等离子体质谱法进行钆定量。通过 Kruskal-Wallis 检验进行统计分析。结果 所有三组的 DCN/脑干 SI 比率均有所增加,但相似 (p = 0.14)。小脑中的钆组织浓度(中位值,nmol/g)分别为 6.7(肿瘤)、6.3(放射治疗)和 6.8(对照)(p = 0.64)以及 17.8/14.6(肿瘤)、20.0/18.9(放射治疗)、原发肿瘤 (p = 0.98) 和大脑对侧半球 (p = 0.41) 分别为 17.8/15.9(对照)。结论 重复给予钆喷替酯 1 周后,通过放疗或单独放疗治疗的实验性脑肿瘤不会改变大鼠脑中的 DCN 信号高信号和钆浓度。这表明局部血脑屏障破坏不会影响大脑中保留的钆量。
更新日期:2019-07-11
down
wechat
bug